148 related articles for article (PubMed ID: 23625134)
21. Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus.
Niiya M; Niiya K; Takazawa Y; Hayashi Y; Tanio Y; Kushiro M; Tanimizu M; Hasegawa H; Tanimoto M
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):361-5. PubMed ID: 12032403
[TBL] [Abstract][Full Text] [Related]
22. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
23. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody to von Willebrand factor in systemic lupus erythematosus.
Soff GA; Green D
J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290
[TBL] [Abstract][Full Text] [Related]
25. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].
Ogata K; Minami S; Kamiya T
Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486
[No Abstract] [Full Text] [Related]
26. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
27. Acquired von Willebrand's syndrome in the course of Waldenström's disease.
Mazurier C; Parquet-Gernez A; Descamps J; Bauters F; Goudemand M
Thromb Haemost; 1980 Dec; 44(3):115-8. PubMed ID: 6781094
[TBL] [Abstract][Full Text] [Related]
28. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
29. Acquired von Willebrand's syndrome: a single institution experience.
Kumar S; Pruthi RK; Nichols WL
Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
[TBL] [Abstract][Full Text] [Related]
30. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
Ishimaru F; Hayashi H; Fujita T; Tsurumi N; Tsuda T; Kimura I
Rinsho Ketsueki; 1990 Sep; 31(9):1493-8. PubMed ID: 2246822
[TBL] [Abstract][Full Text] [Related]
31. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
32. [Inborn and acquired von Willebrand disease].
Schneppenheim R; Budde U
Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
[TBL] [Abstract][Full Text] [Related]
33. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
Caduff T; Straub PW
Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
[TBL] [Abstract][Full Text] [Related]
34. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
Sucker C; Michiels JJ; Zotz RB
Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
[TBL] [Abstract][Full Text] [Related]
35. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
Joist JH; Cowan JF; Zimmerman TS
N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
[TBL] [Abstract][Full Text] [Related]
36. Proceedings: Relationship between factor VIII and von Willebrand's factor in plasma and serum.
Koutts J; Gude N; Firkin B
Thromb Diath Haemorrh; 1975 Nov; 34(2):607. PubMed ID: 1081756
[No Abstract] [Full Text] [Related]
37. [Recent acquisitions concerning the pathogenesis of Von Willebrand's disease].
Morrone G
Pediatria (Napoli); 1977 Dec; 85(4):658-63. PubMed ID: 349496
[No Abstract] [Full Text] [Related]
38. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
[No Abstract] [Full Text] [Related]
39. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
40. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
